"Regional Medical Center (RMC) Health System is the largest not-for-profit healthcare provider in Northeast Alabama. With more than 2,000 employees and over 200 primary care and specialty physicians, RMC provides comprehensive inpatient and outpatient care in cardiology, oncology, orthopedic/joint replacement, emergency care and rehabilitation services. RMC Women’s & Children’s Pavilion in Anniston welcomes more than 2,000 newborns each year and was the first designated baby-friendly hospital in Alabama."

During the past decade, Northeast Alabama Regional Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 23 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northeast Alabama Regional Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 29 trials, followed by "National Cancer Institute (NCI)" with 11 trials sponsored, "SWOG Cancer Research Network" with 11 trials sponsored, "SCRI Development Innovations, LLC" with 7 trials sponsored and "NSABP Foundation Inc" with 7 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeast Alabama Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 46 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Bristol-Myers Squibb" with 4 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Northeast Alabama Regional Medical Center" are "Lung Cancer" (14 trials), "Breast Cancer" (13 trials), "Colorectal Cancer" (6 trials), "Lymphoma" (5 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "Northeast Alabama Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Northeast Alabama Regional Medical Center" are "Drug" (54 trials), "Biological" (18 trials), "Other" (15 trials), "Procedure" (9 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "gemcitabine hydrochloride" (9 trials), "Bevacizumab" (8 trials), "cisplatin" (7 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Northeast Alabama Regional Medical Center" are 44 trials for "All" genders, 15 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Northeast Alabama Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Northeast Alabama Regional Medical Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Northeast Alabama Regional Medical Center, 1 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".